T50.A16
Underdosing of pertussis vaccine, including combinations with a pertussis component
Clinical Classification Guidelines
Medical Intelligence & Overview
Underdosing of the pertussis vaccine, classified under ICD-10 code T50.A16, refers to receiving an insufficient amount of the vaccine intended to protect against pertussis, also known as whooping cough. This condition can occur intentionally or unintentionally, often leading to decreased immunity against the disease. Proper dosing is critical for effective prevention, and underdosing can compromise the vaccine's protective benefits.
Causes & Symptoms
Clinical Causes: Administration error: delivering less than the recommended amount during vaccination. Missing doses: not completing the full vaccination series as scheduled. Manufacturing issues: problems with vaccine dosage during production. Patient-specific factors: conditions affecting absorption or response to the vaccine. Supply chain problems: shortages leading to reduced doses or incomplete vaccination schedules.
Key Symptoms: Lack of immunity to pertussis, increasing risk of infection. Potential exposure to pertussis without effective protection. Signs of pertussis infection if exposed, such as severe coughing fits, though these are not symptoms of the underdosing itself.
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically based on review of vaccination records and clinical history. Healthcare professionals may assess whether the administered vaccine dose meets the recommended guidelines. Laboratory testing for pertussis, such as PCR or culture, may be used if infection occurs. The focus is on confirming the history of vaccine dosing and identifying any deviations from recommended vaccination schedules.
Treatment Protocols: There is no treatment for vaccine underdosing itself. However, if an individual is found to have received an insufficient vaccine dose, healthcare providers may recommend a booster shot or additional doses to ensure adequate immunity. Managing pertussis infections involves antibiotics and supportive care if infection occurs, but the primary goal remains proper vaccination to prevent disease.
Clinical Advice & FAQs
Billing Guidance
Is T50.A16 a billable ICD-10 code?
Yes, T50.A16 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T50.A16?
Clinical documentation must specify the nature of Underdosing of pertussis vaccine, including combinations with a pertussis component and any associated comorbidities for accurate reporting.
Cite this Clinical Reference